Evaluation of omalizumab prescription for asthma patients. Adequacy to the recommendations of the regulatory agencies and asthma guidelines
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- de Rojas, H. F.
- Diaz-Palacios, M.
- Perez-Gomez, A.
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
de Rojas,HF,Gonzalez,R,Diaz,M,Perez,A,Lopez,R,Gimeno,E,Nieto,A. Evaluation of omalizumab prescription for asthma patients. Adequacy to the recommendations of the regulatory agencies and asthma guidelines. World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization. 2013. Milan. 111 RIVER ST, HOBOKEN 07030-5774, NJ:WILEY. 2013 p.p. 364-364.
Portal de investigación